相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I study of the oral platinum agent satraplatin (S) in sequential combination with capecitabine (C) in patients with advanced solid tumours
C. Sessa et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Phase I study of satraplatin and docetaxel in solid malignancies
T. B. Leal et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin
Roman Hrstka et al.
ANTI-CANCER DRUGS (2008)
ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy
In Gyu Hwang et al.
CANCER (2008)
Chemical and biological profiles of novel copper(II) complexes containing s-donor ligands for the treatment of cancer
Lorena Giovagnini et al.
INORGANIC CHEMISTRY (2008)
A phase II study of picoplatin with docetaxel and prednisone in chemotherapy-naive patients with metastatic hormone refractory prostate cancer (HRPC)
H. B. Breitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Final results of a phase I study of picoplatin and pegylated liposomal doxorubicin in advanced solid tumor malignancies
D. S. Dizon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
First-line phase Ib and II studies of picoplatin in combination with 5-fluorouracil and leucovorin (FOLPI) as a potential neuropathy-sparing therapy for colorectal cancer (CRC)
D. A. Karlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta
Caroline Descoteaux et al.
STEROIDS (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Mechanisms of resistance to cisplatin and carboplatin
David J. Stewart
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Oxaliplatin for the treatment of cisplatin-resistant cancer: A systematic review
Britta Stordal et al.
CANCER TREATMENT REVIEWS (2007)
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
Bruce J. Giantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer
Tomislav Dragovich et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells
Viktor Horvath et al.
GYNECOLOGIC ONCOLOGY (2006)
Phase II study of BBR 3464 as treatment in patients with sensitive or refractory small cell lung cancer
Thomas A. Hensing et al.
ANTI-CANCER DRUGS (2006)
Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats
T Uehara et al.
ARCHIVES OF TOXICOLOGY (2005)
Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)
T Latif et al.
INVESTIGATIONAL NEW DRUGS (2005)
A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine
KT Flaherty et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131
KA Gelmon et al.
ANNALS OF ONCOLOGY (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
RM Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A phase II study of ZD0473 given as a short infusion every 3 weeks to patients with advanced or metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group trial, IND 129
KA Gelmon et al.
ANNALS OF ONCOLOGY (2003)
ZD0473 pharmacokinetics in Japanese patients: a Phase I dose-escalation study
H Murakami et al.
EUROPEAN JOURNAL OF CANCER (2002)
A phase II trial of ZD0473 in platinum-pretreated ovarian cancer
ME Gore et al.
EUROPEAN JOURNAL OF CANCER (2002)
Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free interval
ME Gore et al.
EUROPEAN JOURNAL OF CANCER (2002)
Phase II trial of ZD0473 as second-line therapy in mesothelioma
G Giaccone et al.
EUROPEAN JOURNAL OF CANCER (2002)
A phase II trial of JM-216 in cervical cancer: An NCICCTG study
M Trudeau et al.
GYNECOLOGIC ONCOLOGY (2002)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
